Literature DB >> 19023580

Cytokine and immune cell levels in peritoneal fluid and peripheral blood of women with early- and late-staged endometriosis.

H Hassa1, H Mete Tanir, B Tekin, S D Kirilmaz, F Sahin Mutlu.   

Abstract

OBJECTIVE: To investigate the level of cytokines and immune cells in the peripheral blood (PB) and peritoneal fluid (PF) of different stages of endometriosis.
METHODS: A prospective study was conducted to include 97 women with (n 60) and without (n 37) histopathologically confirmed endometriosis. Based on rASRM classification, stage I/II and stage III/IV were categorized as early-and late-staged endometriosis. Prior to surgery, 10 ml of blood was withdrawn from antecubital vein and serum was obtained. Aliquots were made and stored at -70 degrees C until assayed for cytokines. PF was aspirated from the pouch of Douglas. Peripheral and PF samples were analyzed by ELISA in terms of IL-2, IL-4, IL-10 and IFN-gamma. Determinations of T helper, T suppressor, NK, and B cells were assessed by using cluster determinant-3 (CD-3), CD4, CD8, CD25, CD28, CD45, CD16, CD23 and antibodies against early T cell activation antigens such as CD45RA/CD45RO, CD-69 and late activation antigens such as HLA-DR. A multiparameter flow cytometry was applied to detect the cell activation antigen expression.
RESULTS: In terms of cytokine levels in PB and PF's of control group and early- and late-staged endometriosis cases, no significant difference was depicted in the cytokine levels (p > 0.05). Levels of immune cells did not differ between three groups (p > 0.05).
CONCLUSIONS: The result of this study did not show any significant difference in PB and PF cytokine and lymphocyte subgroups between normal and early- and late-staged endometriosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19023580     DOI: 10.1007/s00404-008-0844-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

Review 2.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

3.  Alternative activation of macrophages in rhesus macaques (Macaca mulatta) with endometriosis.

Authors:  Kumari A Smith; Christine B Pearson; Audra M Hachey; Dong-Ling Xia; Lynn M Wachtman
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

4.  Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma.

Authors:  Ali Yavuzcan; Mete Cağlar; Yusuf Ustün; Serdar Dilbaz; Ismail Ozdemir; Elif Yıldız; Atilla Ozkara; Selahattin Kumru
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-12-01

5.  The association between interleukin-4 -590C/T genetic polymorphism, IL-4 serum level, and advanced endometriosis.

Authors:  Andrei M Malutan; Cristina Drugan; Tudor Drugan; Razvan Ciortea; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2016-07-15       Impact factor: 2.085

Review 6.  Relevant human tissue resources and laboratory models for use in endometriosis research.

Authors:  Erin Greaves; Hilary O D Critchley; Andrew W Horne; Philippa T K Saunders
Journal:  Acta Obstet Gynecol Scand       Date:  2017-04-05       Impact factor: 3.636

7.  Multiplex analysis of 40 cytokines do not allow separation between endometriosis patients and controls.

Authors:  Tamara Knific; Dmytro Fishman; Andrej Vogler; Manuela Gstöttner; René Wenzl; Hedi Peterson; Tea Lanišnik Rižner
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

8.  Limited value of pro-inflammatory oxylipins and cytokines as circulating biomarkers in endometriosis - a targeted 'omics study.

Authors:  Yie Hou Lee; Liang Cui; Jinling Fang; Bernard Su Min Chern; Heng Hao Tan; Jerry K Y Chan
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.